Published in Acta Pathol Microbiol Scand on January 01, 1965
Comprehensive molecular characterization of gastric adenocarcinoma. Nature (2014) 11.93
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet (2014) 8.59
Epidemiology of gastric cancer. World J Gastroenterol (2006) 7.67
Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection. J Clin Oncol (2012) 4.48
Laparoscopic versus open subtotal gastrectomy for distal gastric cancer: five-year results of a randomized prospective trial. Ann Surg (2005) 4.35
Inflammation, atrophy, and gastric cancer. J Clin Invest (2007) 4.29
Gastric adenocarcinoma: review and considerations for future directions. Ann Surg (2005) 3.83
Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg (1993) 3.80
Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol (1992) 3.33
Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J Clin Pathol (1994) 3.16
Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet (2010) 3.15
Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg (2000) 2.85
Prognostic significance of signet ring gastric cancer. J Clin Oncol (2012) 2.70
The epidemiology of gastric cancer. Gastric Cancer (2002) 2.58
Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut (1993) 2.47
Epidemiologic features of upper gastrointestinal tract cancers in Northeastern Iran. Br J Cancer (2004) 2.46
Lymph node metastases of gastric cancer. General pattern in 1931 patients. Ann Surg (1989) 2.45
Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology (2009) 2.39
Variation in gene expression patterns in human gastric cancers. Mol Biol Cell (2003) 2.39
Familial gastric cancer: overview and guidelines for management. J Med Genet (1999) 2.38
Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy. Gastroenterology (2011) 2.36
Early gastric cancer in Europe. Gut (1997) 2.34
Enhanced expression of long non-coding RNA HOTAIR is associated with the development of gastric cancer. PLoS One (2013) 2.26
Helicobacter pylori: the cancer link. J R Soc Med (1996) 2.15
Occult disseminated tumor cells in lymph nodes of patients with gastric carcinoma. A critical appraisal of assessment and relevance. Langenbecks Arch Surg (2008) 2.14
Role of intestinal metaplasia in the histogenesis of gastric carcinoma. J Clin Pathol (1980) 2.05
Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg (1999) 2.00
Predicting lymph node status in early gastric cancer. Gastric Cancer (2008) 1.98
Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut (1992) 1.96
Treatment of gastric cancer. World J Gastroenterol (2014) 1.93
Nature meets nurture: molecular genetics of gastric cancer. Hum Genet (2009) 1.87
Cellular and molecular aspects of gastric cancer. World J Gastroenterol (2006) 1.84
Comparison of computed tomography, endosonography, and intraoperative assessment in TN staging of gastric carcinoma. Gut (1993) 1.83
Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J Gastroenterol (2006) 1.82
Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis. Proc Natl Acad Sci U S A (2002) 1.81
Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention. World J Gastrointest Oncol (2012) 1.74
Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev (2014) 1.73
Gastric cancer screening using the serum pepsinogen test method. Gastric Cancer (2006) 1.71
The gastric precancerous cascade. J Dig Dis (2012) 1.70
Incomplete sulphomucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centres. Gut (1985) 1.64
Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer. Br J Cancer (2008) 1.62
The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol (Pozn) (2015) 1.59
Function of apoptosis and expression of the proteins Bcl-2, p53 and C-myc in the development of gastric cancer. World J Gastroenterol (2001) 1.59
Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status. Gut (2007) 1.57
Salt and salted food intake and subsequent risk of gastric cancer among middle-aged Japanese men and women. Br J Cancer (2004) 1.54
Gastric cancer below the age of 55: implications for screening patients with uncomplicated dyspepsia. Gut (1997) 1.54
Gastric cancer: Classification, histology and application of molecular pathology. J Gastrointest Oncol (2012) 1.53
Analysis of Deregulated microRNAs and Their Target Genes in Gastric Cancer. PLoS One (2015) 1.50
Mannan-binding lectin (MBL) polymorphism and gastric cancer risk in Japanese population. Dig Dis Sci (2008) 1.49
Gastric cáncer: Overview. Colomb Med (Cali) (2013) 1.49
SOX9 expression and its methylation status in gastric cancer. Virchows Arch (2012) 1.47
Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray. J Clin Pathol (2006) 1.47
Prognostic value of proliferating cell nuclear antigen in gastric carcinoma. J Clin Pathol (1991) 1.46
RHOA mutation in diffuse-type gastric cancer: a comparative clinicopathology analysis of 87 cases. Gastric Cancer (2015) 1.45
EGFR, HER-2 and KRAS in canine gastric epithelial tumors: a potential human model? PLoS One (2014) 1.44
Her2/neu testing in gastric cancer: evaluating the risk of sampling errors. Ann Oncol (2012) 1.42
Dietary vitamin A intake and incidence of gastric cancer in a general Japanese population: the Hisayama Study. Gastric Cancer (2011) 1.42
Early gastric cancer shows different associations with adipose tissue volume depending on histological type. Gastric Cancer (2008) 1.42
A novel genetic polymorphism of inducible nitric oxide synthase is associated with an increased risk of gastric cancer. World J Gastroenterol (2004) 1.40
Epstein-Barr virus in gastric carcinoma. Am J Pathol (1993) 1.40
Differences in TGF-β1 signaling and clinicopathologic characteristics of histologic subtypes of gastric cancer. BMC Cancer (2016) 1.39
Gastric cancer: overview. Gastroenterol Clin North Am (2013) 1.37
Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet (2015) 1.36
Adenocarcinoma of the stomach. Changing patterns over the last 4 decades. Ann Surg (1987) 1.36
Immunoperoxidase study of the secretory immunoglobulin system and lysozyme in normal and diseased gastric mucosa. Gut (1982) 1.36
Multiple genetic alterations and behavior of cellular biology in gastric cancer and other gastric mucosal lesions:H.pylori infection, histological types and staging. World J Gastroenterol (2000) 1.34
Cdx1 induced intestinal metaplasia in the transgenic mouse stomach: comparative study with Cdx2 transgenic mice. Gut (2004) 1.34
Expression and nuclear localization of Snail, an E-cadherin repressor, in adenocarcinomas of the upper gastrointestinal tract. Virchows Arch (2005) 1.33
Helicobacter Pylori associated global gastric cancer burden. Front Biosci (Landmark Ed) (2009) 1.33
Frequent overexpression of Aurora Kinase A in upper gastrointestinal adenocarcinomas correlates with potent antiapoptotic functions. Cancer (2008) 1.32
Total versus subtotal gastrectomy: surgical morbidity and mortality rates in a multicenter Italian randomized trial. The Italian Gastrointestinal Tumor Study Group. Ann Surg (1997) 1.32
Gastric carcinoma in young adults. Ann Surg (1988) 1.32
The endodermal origin of digestive and respiratory tract APUD cells. Histopathologic evidence and a review of the literature. Am J Pathol (1979) 1.31
Clinical practice guidelines for gastric cancer in Korea: an evidence-based approach. J Gastric Cancer (2014) 1.31
Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site. Cancer Epidemiol Biomarkers Prev (2009) 1.30
Multifactorial etiology of gastric cancer. Methods Mol Biol (2012) 1.29
Development of early gastric cancer 4 and 5 years after complete remission of Helicobacter pylori associated gastric low grade marginal zone B cell lymphoma of MALT type. World J Gastroenterol (2001) 1.28
Gastric epithelial dysplasia. Gut (1999) 1.27
Family history and the risk of gastric cancer. Br J Cancer (2009) 1.27
Gastric-type well-differentiated adenocarcinoma and pyloric gland adenoma of the stomach. Gastric Cancer (2006) 1.26
Aspirin and risk for gastric cancer: a population-based case-control study in Sweden. Br J Cancer (2001) 1.26
Time trend analysis of gastric cancer incidence in Japan by histological types, 1975-1989. Br J Cancer (2001) 1.25
Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity. J Gastrointest Oncol (2011) 1.25
Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival. World J Gastroenterol (2002) 1.25
Circulating VEGF levels in the serum of gastric cancer patients: correlation with pathological variables, patient survival, and tumor surgery. Ann Surg (2002) 1.24
Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration. Br J Cancer (1996) 1.24
Association of Epstein-Barr virus with gastric carcinoma with lymphoid stroma. Am J Pathol (1993) 1.24
Cross talk between hedgehog and epithelial-mesenchymal transition pathways in gastric pit cells and in diffuse-type gastric cancers. Br J Cancer (2008) 1.24
PD-L1 is an independent prognostic predictor in gastric cancer of Western patients. Oncotarget (2016) 1.24
Clinicopathological characteristics of gastric cancer in the elderly. Br J Cancer (1996) 1.23
Relation of number of positive lymph nodes to the prognosis of patients with primary gastric adenocarcinoma. Gut (1996) 1.23
Changing pattern of gastric cancer in Oxfordshire. Gut (1992) 1.23
FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study. Br J Cancer (2014) 1.23
Down-expression of tumor protein p53-induced nuclear protein 1 in human gastric cancer. World J Gastroenterol (2006) 1.22
On the role of heterotopias of the intestinal epithelium in the pathogenesis of gastric cancer. Acta Pathol Microbiol Scand (1951) 1.58
GASTRIC GLANDULAR TUMORS PROVIDED WITH EXCRETORY DUCTS, AND CRITICISM OF THE THEORY OF THE TUMORS ARISING IN HETEROTOPIC PANCREAS; OBSERVATIONS ON THE OCCURRENCE OF ATYPICAL GLANDS IN THE STOMACH. Acta Pathol Microbiol Scand (1964) 0.83
On the pathogenesis of gastric cancer. Acta Unio Int Contra Cancrum (1952) 0.80
The cell structure and secretion in intestinal cancer, with reference to benign epithelial tumours of the bowel. Acta Pathol Microbiol Scand Suppl (1961) 0.79
[On the pathogenesis of gastrointestinal tumors]. Duodecim (1962) 0.75
[Exogenous hemochromatosis]. Duodecim (1961) 0.75
Structural and histochemical cell changes in intestinal cancer. Acta Pathol Microbiol Scand Suppl (1962) 0.75
[Therapeutic possibilities in gastric cancer and factors affecting its prognosis]. Duodecim (1962) 0.75